Skip to main content

Provider

By Emily Olsen | 02:33 pm | January 27, 2023
Elizabeth Bailey, managing director at RH Capital, discusses the women's health investment landscape after the Supreme Court decision that overturned Roe v. Wade.
By Jessica Hagen | 01:55 pm | January 27, 2023
The funds will help the company grow its platform and scale partnerships with life science companies and healthcare systems.
By HIMSS TV | 07:00 am | January 27, 2023
Hospital leaders must focus on improving operations, building new revenue streams, and preventing regulatory risk, according to Nioura Ghazni, a partner in the corporate practice group of Sheppard Mullin’s San Francisco office.
By Jessica Hagen | 03:49 pm | January 26, 2023
Tia opened another LA-based clinic with Cedars-Sinai, and the partners will set up three more brick-and-mortar clinics in Pasadena, Studio City and Culver City.
By Jessica Hagen | 01:12 pm | January 26, 2023
In an exclusive interview, the companies discuss their partnership and TRIPP's investment in Equa Health's pre-seed funding round.
By Emily Olsen | 12:14 pm | January 26, 2023
The company offers a technology platform that aims to help primary care practices find gaps in care and manage the health of their patient populations.
By Jessica Hagen | 11:25 am | January 26, 2023
The Tidepool Loop app connects to compatible continuous glucose monitors and pumps, and helps Type 1 diabetes patients determine whether insulin levels should be adjusted.
By HIMSS TV | 07:00 am | January 26, 2023
National Center for Health Workforce Planning CEO Ziad Nakshabandi discusses the reskilling and upskilling of healthcare workers and how that effort aligns with the Kingdom's Vision 2030 objectives.
By Adam Ang | 12:07 am | January 26, 2023
They seek to identify digital predictive biomarkers of narcolepsy and excessive daytime sleeping.
By Jessica Hagen | 02:50 pm | January 25, 2023
AI-based drug discovery platform Atomic AI, senior lifestyle company Mighty Health, Lithuania-based Oxipit and cybersecurity firm MedCrypt also closed funding rounds.